ArticlePloS one2026
The PROGAIN trial: A randomized controlled trial of high-protein peripheral parenteral nutrition on nitrogen balance and recovery after gastric cancer surgery - study protocol.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07488611 (The PROGAIN Trial), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The PROGAIN Trial : A Randomized Study of Protein-enriched Parenteral Nutrition on Nitrogen Balance and Recovery in Perioperative Gastric Cancer Surgery
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPatients undergoing curative gastrectomy for gastric cancer are vulnerable to perioperative protein loss, negative nitrogen balance and delayed recovery. Conventional peripheral parenteral nutrition (PN) formulations may not provide sufficient protein at clinically practical infusion volumes, and whether high-protein (amino acid-enriched) PN improves postoperative nitrogen balance after gastrectomy has not been tested in a randomized controlled trial. The PROGAIN trial evaluates the effect of perioperative high-protein PN on nitrogen balance and recovery outcomes in this population. METHODS AND ANALYSIS: PROGAIN is a single-center, randomized, open-label, parallel-group superiority trial with blinded laboratory assessment and coded-group analysis of the primary endpoint. The trial will enroll 110 patients with gastric cancer scheduled for curative gastrectomy. Participants are allocated 1:1 to high-protein PN or conventional PN, administered through a peripheral intravenous line on the day before surgery and postoperative day (POD) 1 through POD 5. PN is delivered at a daily caloric target of 20 kcal/kg/day using a stepwise schedule informed by an institutional retrospective audit of oral intake. The primary outcome is nitrogen balance on POD 5, calculated using a simplified Blackburn equation. Secondary outcomes include nutritional indices, skeletal muscle index, glycemic control, postoperative complications classified by Clavien-Dindo grade and functional recovery measures. The primary analysis will compare the two arms using a two-sample t-test in the intention-to-treat population. The trial has 80% power to detect a between-group mean difference of 3 g/day at a two-sided α of 0.05. ETHICS AND DISSEMINATION: The trial is approved by the Institutional Review Board of Soonchunhyang Cheonan Hospital and conducted in accordance with the Declaration of Helsinki and ICH-Good Clinical Practice. Findings will be disseminated through peer-reviewed publication, scientific meetings and results reporting on ClinicalTrials.gov.
trial registrationClinicalTrials.gov, NCT07488611.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.